PMC - Cardiac Most Popular

The PMC - Cardiac panel contains 7 tests with 11 biomarkers.

PMC - Cardiac

  • Apolipoprotein A-1, Cardio IQ™
  • Apolipoprotein B, Cardio IQ™
  • Cardio IQ(R) Homocysteine
  • CARDIO IQ(R) LP PLA2 ACTIVITY
  • Fibrinogen Activity, Clauss
  • hs-CRP, Cardio IQ™
  • Lipoprotein Fractionation, Ion Mobility, Cardio IQ™

The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.

Also known as: Factor I, Fibrinogen, Fibrinogen Activity Clauss

Fibrinogen Activity,

Fibrinogen is a protein produced by the liver. This protein helps stop bleeding by helping blood clots to form. A blood test can be done to tell how much fibrinogen you have in the blood.

Also known as: Ion Mobility, Cardio IQ Lipoprotein Fractionation, Ion Mobility , HDL Subfractions, IDL Subfractions, LDL Subfractions, Lipoprotein Fraction, Lipoprotein Fractionation, Lipoprotein Fractionation Ion Mobility Cardio IQ, Quest Diagnostics has replaced the VAP® Cholesterol Test with Lipoprotein Fractionation, Ion Mobility, Cardio IQ™ test

LDL Particle Number

LDL Peak Size

LDL Pattern

HDL Large

LDL Small

Also known as: Apolipoprotein A-1, Apolipoprotein A1 Cardio IQ, Cardio IQ Apolipoprotein A-1

Apolipoprotein A1

Also known as: Apolipoprotein B Cardio IQ, Cardio IQ Apolipoprotein B

Apolipoprotein B

Also known as: Cardio IQ Homocysteine , Homocysteine, Homocysteine Cardio IQ

HOMOCYSTEINE,

Also known as: Cardio IQ hs-CRP , hsCRP Cardio IQ

Hs Crp

A high-sensitivity CRP (hs-CRP) test may be used by itself, in combination with other cardiac risk markers, or in combination with a lipoprotein-associated phospholipase A2 (Lp-PLA2) test that evaluates vascular inflammation. The hs-CRP test accurately detects low concentrations of C-reactive protein to help predict a healthy person's risk of cardiovascular disease (CVD). High-sensitivity CRP is promoted by some as a test for determining a person's risk level for CVD, heart attacks, and strokes. The current thinking is that hs-CRP can play a role in the evaluation process before a person develops one of these health problems.